Federation Bio is leading the way in developing new platforms that focus on illnesses where the human microbiome can have a healing effect. The company's microbial strategy utilizes naturally existing bacteria in addition to a varied community of supportive bacteria to promote engraftment and long-lasting therapeutic reactions. This strategy holds promise for a wide range of human ailments, including metabolic disorders, cholestatic diseases, cancer, and autoimmune conditions.